Comparison of quality of life and cosmetic result between open and transaxillary endoscopic thyroid lobectomy for papillary thyroid microcarcinoma survivors: A single‐center prospective cohort study

Tingting Li,Zhicheng Zhang,Weisheng Chen,Shitong Yu,Baihui Sun,Xiangqian Deng,Junna Ge,Zhigang Wei,Shangtong Lei,Guoxin Li
DOI: https://doi.org/10.1002/cam4.4766
IF: 4.711
2022-04-25
Cancer Medicine
Abstract:Transaxillary surgery has obvious advantages in terms of HRQoL and cosmetic effects. The role of transaxillary surgery as an alternative strategy for patients with PTMC is worthy of recognition.BackgroundTransaxillary endoscopic thyroidectomy has been introduced to achieve better cosmetic outcomes. However, the benefits of this technology on the patients' health‐related quality of life (HRQoL) remain unclear. We aimed to investigate whether transaxillary endoscopic lobectomy is comparable to conventional open lobectomy in terms of QOL and cosmetic results in order to provide more evidence for establishing appropriate clinical decisions.MethodsBetween August 2019 and May 2020, transaxillary endoscopic lobectomy and conventional open lobectomy were performed in 73 and 99 patients with papillary thyroid microcarcinoma, respectively. HRQoL was assessed at 1, 3, 6, and 12 months after surgery using the Thyroid Cancer‐Specific Quality of Life Questionnaire. The cosmetic outcomes were assessed 12 months after surgery using the Patient and Observer Scar Assessment Scale (POSAS).ResultsNo significant difference was observed in the surgical results between the two groups. However, the data showed that the average operative time and postoperative hospital stay of the transaxillary group were longer than those of the open group (p
oncology
What problem does this paper attempt to address?